Caspase-8 acts as a key upstream executor of mitochondria during justicidin A-induced apoptosis in human hepatoma cells  by Su, Chun-Li et al.
FEBS Letters 580 (2006) 3185–3191Caspase-8 acts as a key upstream executor of mitochondria during
justicidin A-induced apoptosis in human hepatoma cells
Chun-Li Sua,1, Lynn L.H. Huangb,1, Li-Min Huangb, Jenq-Chang Leec,
Chun-Nan Lind, Shen-Jeu Wone,*
a Department of Nursing, Chang Jung Christian University, Tainan 711, Taiwan
b Institute of Biotechnology, College of Science, National Cheng Kung University, Tainan 701, Taiwan
c Department of Surgery, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan
d School of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan
e Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan
Received 14 February 2006; revised 25 April 2006; accepted 27 April 2006
Available online 4 May 2006
Edited by Vladimir SkulachevAbstract Justicia procumbens is a traditional Taiwanese herbal
remedy used to treat fever, pain, and cancer. Justicidin A, iso-
lated from Justicia procumbens, has been reported to suppress
in vitro growth of several tumor cell lines as well as hepatoma
cells. In this study, justicidin A activated caspase-8 to increase
tBid, disrupted mitochondrial membrane potential (Dwm), and
caused the release of cytochrome c and Smac/DIABLO in Hep
3B and Hep G2 cells. Justicidin A also reduced Bcl-xL and in-
creased Bax and Bak in mitochondria. Caspase-8 inhibitor (Z-
IETD) attenuated the justicidin A-induced disruption of Dwm.
Growth of Hep 3B implanted in NOD-SCID mice was sup-
pressed signiﬁcantly by oral justicidin A (20 mg/kg/day). These
results indicate that justicidin A-induced apoptosis in these cells
proceeds via caspase-8 and is followed by mitochondrial disrup-
tion. Supplementary materials are available at http://myweb.
ncku.edu.tw/~a725/.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Human hepatocellular carcinoma (HCC) is the ﬁfth most
frequent cancer and is the third most common cause of can-
cer-related death worldwide [1,2]. In Taiwan, HCC is also a
leading malignant neoplasm [3]. Unfortunately, it does not re-
spond well to chemotherapy and has a poor prognosis [4,5]. To
develop a more eﬀective chemotherapeutic agent for this dis-Abbreviations: HCC, hepatocellular carcinoma; PBMC, peripheral
blood mononuclear cells; Smac/DIABLO, second mitochondria-
derived activator of caspase/direct IAP binding protein with low pI;
PARP, poly(ADP-ribose) polymerase; DFF, DNA fragmentation
factor; Dwm, mitochondrial membrane potential; XIAP, X-linked
apoptosis-inhibiting protein; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide; mAB, monoclonal antibody; pAB,
polyclonal antibody
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doi:10.1016/j.febslet.2006.04.085ease, we concentrated our eﬀorts on natural compounds tradi-
tionally used to treat the disease. Justicia procumbens (J.
procumbens) is a traditional herbal remedy in Taiwan for fever,
pain, and cancer [6,7]. Justicidin A, puriﬁed from a methanolic
extract of J. procumbens, has various biological activities
including suppression of tumor cell growth [8,9] and release
of TNF-a [10]. The purpose of present study was to determine
whether apoptosis is stimulated by justicidin A-treatment of
human HCC. Two major apoptotic pathways (intrinsic and
extrinsic) have been concluded. The intrinsic apoptotic path-
way operates via mitochondria [11]. The extrinsic apoptotic
pathway activates caspase-8 and its downstream regulators
[12]. The results of this study reveal that justicidin A induces
both intrinsic and extrinsic apoptotic pathways in HCC cells
since both caspase-8 and mitochondria are aﬀected. Induction
of apoptosis is characterized by phosphatidylserine external-
ization, accumulation of sub-G1 cells, and DNA fragmenta-
tion. Activation of caspase-8 increases the amount of tBid to
change mitochondrial membrane potential (Dwm), which in
turn causes the release of cytochrome c and second mitochon-
dria-derived activator of caspase/direct IAP binding protein
with low pI (Smac/DIABLO) from mitochondria to activate
caspase-9 and caspase-3. The increase of Bax and Bak and de-
crease of Bcl-xL in mitochondria further promote the process
of apoptosis. The cytotoxicity of justicidin A is also eﬀective
in vivo.2. Materials and methods
2.1. Materials
Justicidin A was isolated from J. procumbens plants [9]. DiOC6(3)
was obtained from Molecular Probes (Eugene, OR). Anti-cytochrome
c mouse monoclonal antibody (mAB) and Annexin V–FITC were pur-
chased from BD Pharmingen (San Diego, CA). Anti-caspase-3 mouse
mAB and anti-Smac/DIABLO rabbit polyclonal antibody (pAB) were
purchased from IMGENEX (San Diego, CA). Anti-caspase-8 mouse
mAB and anti-poly(ADP-ribose) polymerase (PARP) rabbit pAB were
purchased from Cell Signaling Technology (Beverly, MA). Anti-
caspase-9 mouse mAB was purchased from Upstate Biotechnology
(Lake Placid, NY). Anti-receptors for activated C-kinase (RACK1)
mouse mAB was purchased from BD Transduction Laboratories (Lex-
ington, KY). Z-IETD, Z-LEHD, anti-Bax and anti-Bcl-xL mouse
mAB, anti-Bak, anti-DNA fragmentation factor (DFF) 45 and anti-
DFF40 rabbit pAB, and goat anti-mouse conjugated HRP secondary
antibody were purchased from Santa Cruz Biotech (Santa Cruz, CA).blished by Elsevier B.V. All rights reserved.
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from Amersham Pharmacia Biotech (Quebec, Canada). Other reagents
were purchased from Sigma (St. Louis, MO).
2.2. Cell cultures
Human HCC (Hep 3B and Hep G2 cells), and Chang liver cells from
American Type Culture Collection (ATCC, Rockville, MD), were
maintained in complete Dulbecco’s modiﬁed Eagle medium (DMEM;
GIBCO BRL, Grand Island, NY). Human peripheral blood mononu-
clear cells (PBMC) were isolated from healthy donors’ whole blood
(Tainan Blood Bank Center, Tainan, Taiwan) by centrifugation over
a Ficoll-Paque (Amersham Pharmacia, Uppsala, Sweden) density gra-
dient at 400 · g for 30 min in a Sorvall RT6000B (Du Pont, Wilming-
ton, DE) [13]. The cells collected at the interface were washed thrice
with serum-free RPMI-1640 (GIBCO BRL, Grand Island, NY) and
subsequently resuspended in complete DMEM.
2.3. Cell viability assay
Cytotoxicity was determined using a modiﬁed 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assay
[13]. Cells on 96-well plates (Nunc, Roskilde, Denmark) were treated
with diﬀerent concentrations of the test agent for 6 days. After addi-
tion of 10 ll MTT to a ﬁnal concentration of 0.5 mg/ml, cells were
incubated at 37 C for 4 h. After adding 100 ll of 10% SDS/0.01 N
HCl, cells were left overnight at 37 C. The absorbance of each well
was measured at 590 nm in a Multiscan photometer (MRX II, Dyna-
tech, McLean, VA).
2.4. Flow cytometric detection of phosphatidylserine exposure and cell
cycle distribution
Cells were trypsinized, and resuspended in HEPES buﬀer solution
(HBS) containing 1.25% (v/v) of Annexin V–FITC to stain phosphati-
dylserine on the cell surface [14]. Stained cells were analyzed in a FAC-
Scan ﬂow cytometer (Becton Dickinson, Mountain View, CA) [15].
For cell cycle distribution analysis, cells were washed with HBS and
resuspended in 70% ethanol at 4 C. After centrifugation at 800 · g
for 10 min, cells were resuspended in HBS containing 40 lg/ml propi-
dium iodide (PI) and 0.1% NP-40 for ﬂow cytometric analysis [16,17].
2.5. Analysis of DNA fragmentation
Extraction and electrophoresis of DNA were performed as described
[13]. Cells were incubated with lysis buﬀer (10 mM Tris–HCI [pH 7.6],
20 mM EDTA, and 1% NP-40) for 20 min at 37 C. After centrifuga-
tion, the supernatants were incubated with 50 ll of RNase A (20 mg/
ml) and 20 ll of SDS (10%) at 56 C for 2 h. Proteinase K (35 ll of
20 mg/ml) was mixed with the cell lysates and incubated for another
2 h at 37 C. Precipitated DNA fragments were resuspended in 15 ll
of Tris–EDTA buﬀer, and separated by electrophoresis on a 1% (w/
v) agarose gel in TBE buﬀer. The patterns of DNA ladders were exam-
ined after staining with ethidium bromide and under UV light.
2.6. Measurement of Dwm
Change in Dwm was determined by ﬂow cytometry using the mito-
chondria-sensitive dye rhodamine 123 in the dark [16,18]. After treat-
ment, cells were stained with 5 lM rhodamine 123 for 30 min. After
mixing with 2.5 lg/ml of PI, the stained cells were subjected to ﬂow
cytometry, and the data were analyzed using CellQuest software.
Change of Dwm was also determined by laser scanning confocal
microscopy (Leica TCS-SP2, Germany) [16,19]. Cells were seeded in
6-well plates containing methanol-sterilized glass cover slips. After
treatment, the cells were stained with 5 lM rhodamine 123 at 37 C,
washed twice with PBS at room temperature, ﬁxed with 4% parafor-
maldehyde for 15 min, and then examined using a Leica TCSNT laser
scanning confocal imaging system coupled to a Leica DMRBE micro-
scope with a Leica 630 ﬂuotar objective.
2.7. Subcellular fractionation and Western blot analysis
Whole cells (1 · 106) were mixed with 200 ll of lysis buﬀer and then
centrifuged at 15000 · g for 10 min [16]. The supernatant was used as
total protein for immunoblotting. The cytosolic, mitochondrial, and
nuclear proteins were prepared as previously reported [16,20,21].
Brieﬂy, harvested cells (1 · 106) were resuspended in TSE buﬀer(10 mM Tris, 0.25 M sucrose, and 0.1 mM EDTA [pH 7.4]), and
homogenized with 10 strokes in a Dounce homogenizer (Glas-Col,
Terre Haute, IN) using a Teﬂon pestle. After removing the cell debris
by centrifuging the homogenates at 750 · g at 4 C for 30 min, the
supernatants were centrifuged at 12000 · g at 4 C for 30 min. The
supernatants were centrifuged again at 100000 · g for another 1 h.
The resulting supernatants were used as cytosolic fractions, and the
resulting pellets were lysed with lysis buﬀer and used as mitochondrial
fractions. For nuclear extract preparation, cells (1 · 107) were lysed in
400 ll of buﬀer A (10 mM HEPES [pH 7.9], 5 mM MgCl2, 10 mM
KCl, 3 mM Na3VO4, 10 mM NaF, 0.5 mM dithiothreitol, 0.5 mM
phenylmethylsulfonyl ﬂuoride, and 2 lg/ml of leupeptin, antipain,
aprotinin, and pepstatin A) on ice for 20 min. After centrifugation at
11000 · g for 20 s at 4 C, the pellets were resuspended in 60 ll of buf-
fer B (20 mMHEPES, pH 7.9, 1.5 mMMgCl2, 420 mMNaCl, 0.2 mM
EDTA, 25% glycerol, 1 mM Na3VO4, 10 mM NaF, 0.5 mM dithio-
threitol, 0.5 mM phenylmethylsulfonyl ﬂuoride, and 1 lg/ml each of
leupeptin, antipain, aprotinin, and pepstatin A) for 15 min on ice with
occasional mixing. Nuclear debris was removed by centrifugation
again at 12000 · g for 15 min at 4 C. All isolated proteins were stored
at 70 C before immunoblotting analysis [22].
2.8. Animal study
NOD.CB17-PRKDCÆSCIDæ/J (NOD-SCID) mice were bred and
maintained at the Animal Center of National Cheng Kung University
(NCKU, Tainan, Taiwan) in a speciﬁc pathogen-free environment.
Mice at 6–7 weeks of age were used in the experiments as described
previously [16]. Food and water were provided ad libitum. Tumor vol-
ume was measured using calipers (2–3 times/week) [23].
2.9. Statistical analysis
All of the experimental data are expressed as means ± S.E.M. Diﬀer-
ences in tumor volumes were determined by Student’s t test using the
Minitab (version 10.2) software package. We assigned statistical signif-
icance if P < 0.05.3. Results
3.1. Growth inhibition and apoptosis of justicidin A-treated cells
Low dosages of justicidin A suppressed the viability of HCC
Hep 3B and Hep G2 cells, and the IC50 at day 6 was
0.048 ± 0.020 and 0.052 ± 0.050 lM, respectively. The IC50
of justicidin A for non-malignant Chang liver cells was
0.95 ± 0.12 lM, which is at least 10-fold higher than the IC50
of justicidin A for HCC cells. Human PBMC were much more
resistant to justicidin A treatment with an IC50 of 23 ± 1 lM.
To examine the possible mechanism of justicidin A on cell via-
bility, three parameters of apoptosis (exposure of phosphati-
dylserine, cell cycle redistribution and DNA fragmentation)
were analyzed. As shown in Fig. 1A, the percentage of Annex-
in V–FITC positive cells were increased signiﬁcantly in a dos-
age- and time-related manner. Dose-related elevations in the
sub-G1 fraction of both tumor cells were also observed (Sup-
plementary Fig. 1). Justicidin A also caused time- and dose-
related enhancement of apoptotic DNA fragmentation in these
cells (data not shown).3.2. Activation of caspases and involvement of mitochondria in
justicidin A-induced apoptosis
The process of apoptosis involves a cascade of proteolytic
activity, much of it carried out by caspases [21]. In this study,
both procaspase-8 (Fig. 1B) and procaspase-9 (Supplementary
Fig. 2) were cleaved into their active forms in a time-related
manner. Cleavage of their downstream molecule procaspase-
3 was also revealed (Supplementary Fig. 2). Since PARP and
DFF are substrates of activated caspase-3 [24–26], increase
Fig. 1. Induction of apoptosis and expression of caspase-8, cytochrome c and Smac/DIABLO in hepatoma cells in response to justicidin A.
Externalization of phosphatidylserine in Hep 3B and Hep G2 cells (A). After treatment with the indicated concentrations of justicidin A for 48 h or
with 1 lM of justicidin A for the indicated time periods, cells (2 · 105) stained with Annexin V–FITC were analyzed by ﬂow cytometry. The
percentages in the ﬁgure indicate the proportion of apoptotic cells with externalization of phosphatidylserine. Activation of caspase-8, and release of
cytochrome c and Smac/DIABLO in Hep 3B and Hep G2 cells (B). Total proteins from justicidin A-treated cells were subjected to Western blot
analysis to determine the activation of procaspase-8 by using anti-caspase-8 mouse mAB. RACK1 was served as a loading control. Blots of the
cytosol- and mitochondria-enriched fractions were used to demonstrate the translocation of cytochrome c and Smac/DIABLO using anti-cytochrome
cmouse mAB or anti-Smac/DIABLO rabbit pAB. Relative protein expression is shown at the bottom of each panel, with control levels arbitrarily set
to 1. JA, justicidin A.
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Fig. 2) displayed the enzymatic activity of caspase-3. The
involvement of caspase-8 and caspase-9 in the process of apop-
tosis was conﬁrmed by showing that the presence of caspase-8
inhibitor (Z-IETD) or caspase-9 inhibitor (Z-LEHD) reduced
the number of justicidin A treated cells in the sub-G1 phase
(Supplementary Fig. 3).
Activation of caspase-9 (Supplementary Fig. 2) implied the
involvement of mitochondria in justicidin A-induced apopto-
sis. Maintenance of Dwm is important for normal function
and survival of cells [27]. Changes of Dwm can cause the re-
lease of apoptogenic proteins. In this study, the time-related
release of cytochrome c and Smac/DIABLO from mitochon-
dria to cytosol (Fig. 1B) further demonstrated the pivotal role
of mitochondria in justicidin A-induced apoptosis. Con-
versely, mitochondrial cytochrome c decreased gradually in
both cells (Fig. 1B). Similar patterns of increased cytosolic
and decreased mitochondrial Smac/DIABLO were observed
(Fig. 1B). Anti-X-linked apoptosis-inhibiting protein (XIAP),
an antagonist of caspase-3 and caspase-9 [28], was reported
to be antagonized by cytosolic Smac/DIABLO [29]. Decrease
in XIAP expression (data not shown) may therefore favor
the increase in caspase-9 and -3 activities (Supplementary
Fig. 2). Involvement of mitochondria was also conﬁrmed by
changes in Dwm upon justicidin A stimulation. A dose- and
time-related decrease in the intensity of rhodamine 123
ﬂuorescence was detected in the mitochondria of justicidin
A-treated Hep 3B cells (Supplementary Fig. 4). A similar
time-related decrease in ﬂuorescence intensity was observed
in Hep G2 cells (data not shown). Confocal microscopy also
showed that justicidin A induced Dwm. Decrease in ﬂuores-
cence emission was found in both tumor cells after justicidin
A treatment (Fig. 2A).
Fig. 2A reveals the relationship between mitochondria and
caspase-8. In both cells, Z-IETD (an inhibitor of caspase-8)
alleviated the justicidin A-induced decrease in mitochondrial
ﬂuorescence signals (Fig. 2A) and justicidin A-induced in-
crease in the number of apoptotic cells in the sub-G1 fraction
(Supplementary Fig. 3). Similar results were observed when
cells were treated with justicidin A plus cyclosporin A, a per-
meability transition pore inhibitor that blocks the release of
cytochrome c from mitochondria (Fig. 2A).
3.3. Involvement of Bcl-2 family in justicidin A-induced
apoptosis
Members of Bcl-2 family regulate apoptosis by interacting
with mitochondria [28]. Bcl-2 and Bcl-xL protect against mito-
chondrial dysfunction and therefore inhibit apoptosis. In con-
trast, Bid, Bax, and Bak induce Dwm and thus promote
apoptosis. To test the involvement of the proteins of the Bcl-
2 family in justicidin A-induced apoptosis, total cell lysates,
and cytosolic and mitochondrial fractions of justicidin A-
treated tumor cells were prepared. In Fig. 2B, justicidin A
signiﬁcantly decreased total and mitochondrial Bcl-xL. Trans-
location of Bax was also observed in these two cells after
treatment of justicidin A (Fig. 2B). The expression of cytosolic
Bax decreased and the mitochondrial Bax increased (Fig. 2B).
In Hep 3B cells, mitochondrial Bak expression increased a
small amount, whereas, in Hep G2 cells it increased markedly
(Fig. 2B). Cytosolic Bid was decreased after treatment with
justicidin A (Fig. 2B). The translocation of the tBid fragment
to mitochondria began at 6 h of justicidin A treatment, keptincreasing between 12 and 24 h, and peaked at 72 h in Hep
3B cells or at 48 h in Hep G2 cells (Fig. 2B).
3.4. Tumor growth in mice
To examine the antitumor eﬀect of justicidin A in vivo,
Hep 3B cells were implanted in mice before they were fed jus-
ticidin A (20 mg/kg/day) for 60 consecutive days. As shown
in Fig. 3, the tumors were sensitive to justicidin A, and their
growth was halted throughout the period of justicidin A
administration.4. Discussion
Our experimental ﬁndings suggest the following signaling
cascades in justicidin A-treated HCC. At 6 h of justicidin A
treatment, activation of caspase-8 (Fig. 1B) triggers the cleav-
age of Bid into tBid and causes the translocation of tBid to
mitochondria (Fig. 2B). Mitochondrial tBid may oligomerize
with the mitochondrial Bax (Fig. 2B) and Bak (Fig. 2B) (both
proteins ﬁrst increase in the mitochondria at 6 h of justicidin A
treatment) to damage Dwm (Fig. 2A and Supplementary
Fig. 4) and result in releasing cytochrome c and Smac/DIA-
BLO into the cytosol at a later time point (at 24 h in Hep 3B
and 48 h in Hep G2 cells) (Fig. 1B). Since Bcl-xL can bind to
Bax and prevent Bax insertion into the outer membrane of
mitochondria [30], the decrease in total and mitochondrial
Bcl-xL (Fig. 2B) promotes the changes of Dwm. The released
cytochrome cmay contribute to the formation of apoptosomes
in the cytosol to activate caspase-9 (Supplementary Fig. 2).
Decrease in XIAP (data not shown), because of interaction
with the cytosolic Smac/DIABLO, may further increase apop-
tosome formation and therefore facilitate caspase-9 activation
[28]. The activation of caspase-8 or caspase-9 subsequently
activates caspase-3 (Supplementary Fig. 2). The activated cas-
pase-3 then cleaves PARP (Supplementary Fig. 2). Since
PARP participates in DNA repair mechanism [31,32], the in-
crease in cleaved PARP disables the function of DNA repair
in both cells. The activated caspase-3 also cleaves DFF45
(Supplementary Fig. 2). Since DFF45 can bind DFF40 to pre-
vent DFF40-mediated DNA fragmentation [33], the decrease
in DFF45 allows release of DFF40 into the nucleus. The in-
crease in nuclear DFF40 (Supplementary Fig. 2) may result
in the formation of DNA ladders in justicidin A-treated
HCC (data not shown). Greater increase in the level of cleaved
PARP than nuclear DFF40 (Supplementary Fig. 2) in Hep 3B
cells suggests that PARP is the more important determinant of
DNA fragmentation in these cells. The small increase in pro-
apoptotic Bak (Fig. 2B) in Hep 3B cells suggests that caspase
activation and Bax-dependent release of mitochondrial apop-
togenic proteins are suﬃcient to increase the level of cleaved
PARP and nuclear DFF40 (Supplementary Fig. 2) and thereby
to provoke Hep 3B cell death. Our results indicate that Hep
G2 but not Hep 3B cells express Bcl-2 (data not shown). Since
Bcl-2 protein has been reported to inhibit caspase-8 activity
[34,35], the greater increase in cleaved caspase-8 in Hep 3B
cells (Fig. 1B) may be explained. Greater cleavage of procas-
pase-8 (Fig. 1B) may result in more predominant increase in
mitochondrial tBid and tBid-induced translocation of Bax
(Fig. 2B), and thereby lead to the greater increase in cleaved
caspase-3 (Supplementary Fig. 2) in Hep 3B cells. Recently,
Bak has been reported to be a mitochondrial membrane pro-
Fig. 2. Changes of Dwm and expressions of proteins involved in mitochondria-dependent apoptosis induced by justicidin A treatment. Inhibitory
eﬀects of Z-IETD or cyclosporin A on Dwm and on the percentage of cells in the sub-G1 fraction were evaluated respectively by confocal microscopy
and ﬂow cytometry (A). In the experiment, cells were pretreated with 20 lM of Z-IETD or 10 lM of cyclosporin A for 4 h prior to the addition of
justicidin A (1 lM) for 30 h. Cells were either stained with rhodamine 123 for confocal microscopy or stained with PI for ﬂow cytometry. Expression
of death related proteins in justicidin A-treated hepatoma cells (B). Blots were developed with anti-Bcl-xL or anti-Bax mouse mAB, or with anti-Bak
or anti-Bid rabbit pAB.
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Fig. 3. Suppression of tumor growth in NOD-SCID mice. Hep 3B
cells (3.2 · 105 cells/mice) were implanted s.c. into the ﬂanks of mice on
day 0. On day 4, the animals were randomly assigned to two groups.
The mice in the treatment group (s, n = 5) were fed justicidin A
(20 mg/kg/day), and the mice in the control group (d, n = 5) were fed
vehicle (0.05% dimethyl sulfoxide in normal saline) for another 60 days
until the end of the experiment. The growth of tumors was recorded.
An arrowhead indicates the starting time of justicidin A treatment.
 indicates signiﬁcantly diﬀerent from the corresponding control
group, P < 0.05.
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upon justicidin A treatment in HCC cells. Similar result was
also reported in Hep G2 cells [36]. The predominant increase
in mitochondrial Bak in Hep G2 than in Hep 3B cells may
be due to the greater increase in total Bak protein expression
in Hep G2 cells upon justicidin A stimulation (data not
shown). However, the mitochondrial Bak in Hep G2 cells
might not all be in oligomerized form for cytochrome c release
(Fig. 1B). Of note, the control of caspase-8 inhibitor (Z-IETD)
on Dwm (Fig. 2A) indicates that caspase-8 is an upstream reg-
ulator of mitochondria in justicidin A-induced apoptosis. The
total blockage of justicidin A-induced apoptosis by either
cyclosporine A (Fig. 2A) or caspase-9 inhibitor (Z-LEHD)
(Supplementary Fig. 3) demonstrates that this apoptotic pro-
cess is mitochondria- and caspase-9-dependent, and the direct
activation of caspase-3 by caspase-8 only plays a minor role in
justicidin A-induced apoptosis.
Both the intrinsic and extrinsic pathways were induced in
the HCC cells since both caspase-8 (Fig. 1B) and mitochon-
dria (Fig. 2A and Supplementary Fig. 4) were aﬀected by jus-
ticidin A. Our previous experiments indicated that only the
intrinsic pathway is stimulated by justicidin A in colorectal
carcinoma cells [16], in which, caspase-8 was not activated
in either HT-29 or HCT 116 cells. The justicidin A-induced
apoptotic pathway in colorectal carcinoma cells begins with
the suppression of Ku70, which causes the translocation of
Bax to mitochondria. The change of Dwm causes the release
of apoptogens (cytochrome c and Smac/DIABLO) to further
activate their downstream regulators. In contrast, in these
HCC cells, alteration of Ku70 expression was not detected
(data not shown).
In conclusion, justicidin A inhibits the growth of HCC cells
in vitro and in vivo. Induction of apoptosis is the result of jus-
ticidin A cytotoxicity. The lower sensitivity of PBMC to jus-
ticidin A illustrates that this natural compound, justicidin A,
is selective against malignant cells.Acknowledgement: This work was supported by a grant from National
Science Council, Taipei, Taiwan, ROC (NSC 91-2320-B-006-075).Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.febslet.2006.
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